Fmoc-Asp(ODmab)-OH

Fmoc-Asp(ODmab)-OH is an Fmoc-protected aspartic acid derivative bearing a side-chain carboxylic acid masked as an ODmab ester, where the stereogenic center corresponds to the natural L-aspartate configuration. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino functionality with a protected side-chain carboxylate that is designed to remain stable under common peptide-coupling conditions while enabling controlled release during deprotection. The presence of the Fmoc carbamate and the ODmab ester establishes a predictable orthogonal protection pattern, supporting iterative solid-phase or solution-phase assembly of Asp-containing sequences. The resulting reactivity profile includes Fmoc deprotection under base and side-chain unmasking under conditions compatible with ODmab removal, positioning the compound as a chiral peptide building block and derivatization intermediate for downstream functionalization.

1. Peptide Synthesis

Fmoc-Asp(ODmab)-OH is applied in peptide synthesis as an Asp side-chain protected building block for constructing peptides and peptidomimetics that require controlled handling of the second carboxyl group. The Fmoc group enables orthogonal N-terminal protection, while the ODmab-protected side-chain carboxylate supports peptide coupling without premature side-chain interference. The chiral L-aspartate stereocenter is retained through coupling steps, supporting stereochemically defined peptide analogs used in sequence mapping and scaffold design. The protected side-chain can be unmasked after chain assembly to yield a free β-carboxyl functionality for subsequent conjugation, salt formation, or further derivatization, aligning with standard amino acid chemistry workflows.

2. Side-Chain Functionalization

Fmoc-Asp(ODmab)-OH is utilized for side-chain functionalization strategies where the β-carboxyl group of aspartate must be generated on demand for chemical modification. The ODmab ester acts as a temporary protecting group that suppresses uncontrolled acylation or salt formation during earlier synthetic stages, while the Fmoc carbamate maintains N-protection for selective peptide bond formation. Unmasking of the side-chain carboxylate after Fmoc removal can enable conversion to activated esters, amides, or other carboxyl-derived derivatives that participate in bioconjugation chemistries. The stereodefined Asp framework supports installation of functional groups at a defined spatial position, supporting structure-activity relationship studies and chemically defined labeling of Asp-containing biomolecules.

3. Chemical Biology Labeling

Fmoc-Asp(ODmab)-OH serves in chemical biology workflows that require incorporation of a protected Asp residue into peptide probes prior to labeling or post-synthetic modification. The protected β-carboxyl group allows assembly of peptide recognition motifs while preventing side reactions that could compromise probe integrity during coupling and purification. The combination of Fmoc-controlled N-deprotection and ODmab-controlled side-chain release supports staged generation of reactive carboxyl functionality for attachment of tags such as linkers, affinity handles, or reporter moieties. The resulting labeled peptide probes can be used to interrogate binding interfaces, map interaction surfaces, or generate chemically defined reagents for biochemical assays, leveraging amino acid protection logic to control functional group timing.

4. Pharmaceutical Intermediate Preparation

Fmoc-Asp(ODmab)-OH is suitable for pharmaceutical intermediate preparation where protected amino acid derivatives are required to build peptide-like fragments or carboxyl-functionalized intermediates under controlled protection schemes. The Fmoc group provides a robust N-protection handle for manufacturing-oriented peptide coupling steps, while the ODmab ester supports chemoselective handling of the Asp side-chain carboxylate during intermediate isolation. The stereogenic L-aspartate configuration supports consistent composition of chiral peptide fragments used in medicinal chemistry and process development. Downstream unmasking of the side-chain can generate free carboxyl groups for salt formation, further derivatization, or incorporation into larger synthetic sequences, aligning with industrial fine chemical synthesis practices for chiral, protected building blocks.

5. Process Chemistry Intermediate

Fmoc-Asp(ODmab)-OH is applied as a process chemistry intermediate for scalable preparation of Fmoc-protected Asp residues used in solid-phase peptide synthesis and related manufacturing routes. The orthogonality between Fmoc deprotection and ODmab side-chain unmasking supports predictable stepwise transformations, reducing the likelihood of cross-reactivity between protected functional groups. The protected amino acid format facilitates standardized coupling chemistry and downstream isolation of intermediates with defined functional group states, supporting reproducible production of Asp-containing sequences. The chiral, protected structure also supports consistent downstream conversion to deprotected Asp-containing peptides or carboxyl-functional derivatives used in industrial chemical manufacturing and applied peptide science.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

3. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats